KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Merck (MRK) Accumulated Depreciation & Amortization (2016 - 2025)

Merck (MRK) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $19.2 billion as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 4.87% to $19.2 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $19.2 billion, a 4.87% increase, with the full-year FY2024 number at $19.2 billion, up 4.87% from a year prior.
  • Accumulated Depreciation & Amortization was $19.2 billion for Q4 2024 at Merck, up from $18.3 billion in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $19.2 billion in Q4 2024 to a low of $143.0 million in Q4 2020.
  • A 5-year average of $4.7 billion and a median of $367.0 million in 2020 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 80.38% in 2020, then surged 9936.26% in 2023.
  • Merck's Accumulated Depreciation & Amortization stood at $143.0 million in 2020, then skyrocketed by 132.17% to $332.0 million in 2021, then tumbled by 45.18% to $182.0 million in 2022, then soared by 9936.26% to $18.3 billion in 2023, then increased by 4.87% to $19.2 billion in 2024.
  • Per Business Quant, the three most recent readings for MRK's Accumulated Depreciation & Amortization are $19.2 billion (Q4 2024), $18.3 billion (Q4 2023), and $182.0 million (Q4 2022).